COPD Trial, Recruiting NCT06956742 Sponsor: ADIR Association Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT06956742
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults over 18 years of age
  • People who have been diagnosed with moderate to very severe COPD (classified as GOLD stage II, III, or IV)
  • People who have already completed a pulmonary rehabilitation program at the trial site
  • People whose 6-minute walk test result was less than 350 meters, either before or after completing pulmonary rehabilitation
  • People who experience significant breathlessness in daily life, rated at level 2 or higher on a standard breathlessness scale
  • People whose lungs trap an excessive amount of air (a condition called pulmonary hyperinflation, confirmed by specific lung volume measurements)
  • People who use supplemental oxygen or those who do not
  • People whose condition has been stable for at least the last 4 weeks, with no flare-ups or changes to their treatment
  • People who have never previously received a treatment called intermittent intrapulmonary deflation
  • People who are affiliated with social security and have read, understood, and signed the study consent form

Who may not be able to join:

  • People who are pregnant or may become pregnant
  • People who are under legal guardianship or a similar protected legal arrangement
  • People who are unable to give their own informed consent
  • People whose primary lung diagnosis is a condition other than COPD, such as asthma or primary bronchiectasis
  • People who have bone, nerve, blood vessel, or muscle conditions that affect their ability to walk, or who require a walking aid
  • People with serious or unstable heart conditions, such as uncontrolled irregular heartbeat, severe heart failure, a recent heart attack, or unstable chest pain
  • People who currently need assisted breathing through a tube, mask, or breathing machine, or who have a condition causing weakness in the breathing muscles, or who cannot cough strongly on their own
  • People whose circulation or blood pressure is currently unstable
  • People who have had a collapsed lung (pneumothorax) within the last 3 months
  • People who have had surgery on their lungs or upper airways within the last month
  • People who have been referred to pulmonary rehabilitation as preparation for chest surgery, such as lung volume reduction, lung transplant, or lung cancer surgery
  • People who are using or plan to use an electrical or mechanical airway clearance device during the study period (such as a cough assist machine or chest oscillation vest)
  • People with an active cancer diagnosis
  • People who have had a severe episode of coughing up blood within the last 3 months
  • People who have a severe condition causing the windpipe to collapse (severe tracheomalacia)
  • People who withdraw their consent after joining
  • People who experience a COPD flare-up or develop heart or breathing instability between study visits

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tristan Bonnevie, PhD, Association ADIR

Phone: 0235592970

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
ADIR Association
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
28 February 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Sensory dimension of dyspnea

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov